Abstract:Abstract The von Hippel Lindau (VHL) tumor suppressor gene is a classical tumor suppressor whose biallelic inactivation is a truncal event in clear cell renal cell carcinoma (ccRCC) evolution. VHL is best characterized as the recognition component of an E3 ubiquitin ligase complex that targets hypoxia inducible transcription factors (HIF1A and HIF2A) for conditional oxygen-dependent degradation. HIF activation following VHL inactivation is an early event in ccRCC progression. While the functions of HIF1A and HIF2A in ccRCC biology and progression have been studied, those in VHL-null non-neoplastic cells of the renal tubular epithelium (RTE) and their contribution to tumorigenesis have not been fully explored. Here, using a combination of lineage marking and single-cell RNA sequencing (scRNA-seq), we provide the first description of HIF1A- and/or HIF2A-dependent and -independent consequences of in vivo Vhl inactivation in the RTE with single-cell resolution. We have previously reported on the development of a novel mouse model designed to mark and track cells that have undergone Vhl inactivation in vivo. Using this model, we have shown that Vhl inactivation has extensive, cell-type specific effects on gene expression in cells of the RTE within 3 weeks of recombination. Furthermore, we have shown that over a course of 4-8 months after Vhl inactivation, Vhl-null cells undergo specific adaptive changes in gene expression that encompass genes not regulated early after Vhl inactivation. In the work reported here, we have coupled this mouse model to a tamoxifen-inducible RTE-specific Pax8-CreERT2 and conditional alleles for Hif1a and/or Epas1 (codes for HIF2A). We have analyzed ‘marked’ recombined cells at early (1-3 weeks) or late (4-8 months) timepoints after recombination and compared these cells to time-matched Vhl-null cells using immunohistochemistry, in situ RNA hybridization and scRNA-seq. We found that though both HIF isoforms were present in Vhl-null cells at the early timepoint, expression of genes regulated early after Vhl inactivation was affected more by Hif1a inactivation than Epas1 inactivation. In contrast, expression of genes that are regulated in Vhl-null cells over time was drastically impacted by Epas1 deletion but was unaffected by Hif1a deletion. Interestingly, most of these Epas1-dependent, time-dependent changes in Vhl-null cells involved genes that have not been identified as direct transcriptional targets of HIF. Collectively, our work suggests that HIF1A and HIF2A have temporally distinct contributions to gene expression in Vhl-null cells in the RTE. We are currently analyzing the cell-type specificity of these contributions and ascertaining their relevance to the adoption of ccRCC-associated gene expression profiles. Citation Format: Samvid Kurlekar, Joanna Lima, Ayslan B. Barros, Norma Masson, Sophia Zhai, Christopher W. Pugh, Julie Adam, Peter J. Ratcliffe. HIF1A and HIF2A differentially contribute to early and adaptive changes following in vivo Vhl inactivation in the kidney [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3024.

Von Hippel-Lindau Tumor Suppressor Protein Regulates the Assembly of Intercellular Junctions in Renal Cancer Cells Through Hypoxia-Inducible Factor-Independent Mechanisms

Regulation of Renal Epithelial Tight Junctions by the Von Hippel-Lindau Tumor Suppressor Gene Involves Occludin and Claudin 1 and is Independent of E-Cadherin

Inadequate Activation of the GTPase RhoA Contributes to the Lack of Fibronectin Matrix Assembly in Von Hippel-Lindau Protein-defective Renal Cancer Cells

Hypoxia-Inducible Factor-1, and Tumor Vascularization

HIFalpha isoform specific activities drive cell-type specificity of VHL-associated oncogenesis

Vhl And Hypoxia Signaling: Beyond Hif In Cancer

Role of VHL Gene Mutation in Human Cancer

Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein

Vhl Inactivation Induces Hef1 and Aurora Kinase A

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Pvhl Acts As a Downstream Target of E2F1 to Suppress E2F1 Activity.

Expression of the Hypoxia-Inducible Factors in the AML and MDS: is Not Associated with the Von Hippel-Lindau Gene

Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma

Formation of Primary Cilia in the Renal Epithelium is Regulated by the Von Hippel-Lindau Tumor Suppressor Protein

Phosphorylation-dependent Cleavage Regulates Von Hippel Lindau Proteostasis and Function.

Total loss of VHL gene function impairs neuroendocrine cancer cell fitness due to excessive HIF2α activity

VHL suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation

Abstract 3024: HIF1A and HIF2A differentially contribute to early and adaptive changes following in vivo Vhl inactivation in the kidney

VHL Ser65 Mutations Enhance HIF2α Signaling and Promote Epithelial-Mesenchymal Transition of Renal Cancer Cells

CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma

Identification of Novel VHL Regulated Genes by Transcriptomic Analysis of RCC10 Renal Carcinoma Cells.